- Investing Ideas
- U.S. Big Pharma, Big Dividends
U.S. Big Pharma, Big Dividends
Results
7
Large pharmaceutical stocks to buy with strong dividend features.
7 companies
Johnson & Johnson
Market Cap: US$598.7b
Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJ
US$248.56
7D
1.1%
1Y
48.6%
Merck
Market Cap: US$306.1b
Operates as a healthcare company worldwide.
MRK
US$121.41
7D
-1.9%
1Y
30.3%
Bristol-Myers Squibb
Market Cap: US$127.0b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$62.34
7D
1.8%
1Y
4.1%
Zoetis
Market Cap: US$55.3b
Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
ZTS
US$128.96
7D
2.5%
1Y
-24.4%
Phibro Animal Health
Market Cap: US$2.2b
Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.
PAHC
US$54.54
7D
5.9%
1Y
122.4%
Pfizer
Market Cap: US$157.2b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$27.26
7D
0.7%
1Y
3.8%
Royalty Pharma
Market Cap: US$26.7b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$47.47
7D
4.4%
1Y
40.2%